Related references
Note: Only part of the references are listed.The importance of hsa-miR-28 in human malignancies
Seyede Fatemeh Hosseini et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Risk of Breast Cancer in Selected Women With Atypical Ductal Hyperplasia Who do not Undergo Surgical Excision
Lyndsey J. Kilgore et al.
ANNALS OF SURGERY (2022)
Risk management recommendations and patient acceptance vary with high-risk breast lesions
Anna C. Beck et al.
AMERICAN JOURNAL OF SURGERY (2022)
Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study
Lakshmi Vineela Nalla et al.
MOLECULAR BIOLOGY REPORTS (2022)
Noncoding RNA actions through IGFs and IGF binding proteins in cancer
Aidan Kerr et al.
ONCOGENE (2022)
Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
Raj Pranap Arun et al.
BIOMEDICINES (2022)
The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target
Ji-Sun Lee et al.
LIFE-BASEL (2022)
Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway
Xiaochen Zan et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2022)
Risk factors for breast cancer in women: an update review
Nada Fakhri et al.
MEDICAL ONCOLOGY (2022)
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution
Xiaoxian Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Combined analysis of miR-200 family and its significance for breast cancer
Andrea Fontana et al.
SCIENTIFIC REPORTS (2021)
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
Ilaria Cavallari et al.
CANCERS (2021)
Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1
Shuiyi Liu et al.
BREAST CANCER RESEARCH (2021)
Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines
Alana A. Lewin et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼ 430 000 women
N. Murphy et al.
ANNALS OF ONCOLOGY (2020)
microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2
Yuanwen Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Integrated analysis identifies low microRNA-215 expression as associated with a poor prognosis of patients with colorectal cancer through the IKβ-α signaling pathway
Zhuo Wang et al.
TRANSLATIONAL CANCER RESEARCH (2020)
proteiNorm - A User-Friendly Tool for Normalization and Analysis of TMT and Label-Free Protein Quantification
Stefan Graw et al.
ACS OMEGA (2020)
Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort
Kelsey R. Monson et al.
BREAST CANCER RESEARCH (2020)
Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
Chara Papadaki et al.
Oncotarget (2019)
sRNAbench and sRNAtoolbox 2019: intuitive fast small RNA profiling and differential expression
Ernesto Aparicio-Puerta et al.
NUCLEIC ACIDS RESEARCH (2019)
Circulating microRNAs in plasma among men with low-grade and high-grade prostate cancer at prostate biopsy
Alicia C. McDonald et al.
PROSTATE (2019)
MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1
Junyong Zhao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer
Jianlin Chen et al.
PEERJ (2019)
miRNA-215-5p suppresses the aggressiveness of breast cancer cells by targeting Sox9
Jia Bao Gao et al.
FEBS OPEN BIO (2019)
Circulating miR-130b- and miR-21-based diagnostic markers and therapeutic targets for hepatocellular carcinoma
Nannan Zhang et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Vacuum assisted breast biopsy (VAB) excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia
Simone Schiaffino et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature
Michael Co et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Diagnosis and Management of High-Risk Breast Lesions
Parijatham S. Thomas
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Chromatogram libraries improve peptide detection and quantification by data independent acquisition mass spectrometry
Brian C. Searle et al.
NATURE COMMUNICATIONS (2018)
MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression
T. B. Hu et al.
NEOPLASMA (2018)
Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer
Yaohui Wang et al.
CELL DEATH DISCOVERY (2018)
Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia
Rhiana S. Menen et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy
Liang-Liang Li et al.
ONCOTARGET (2017)
Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy
Tehillah S. Menes et al.
JAMA ONCOLOGY (2017)
MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway
Yuan Miao et al.
SCIENTIFIC REPORTS (2017)
Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia
Alvaro Pena et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1
Yongqin Pan et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Extent of Atypical Hyperplasia Stratifies Breast Cancer Risk in 2 Independent Cohorts of Women
Amy C. Degnim et al.
CANCER (2016)
Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis
Dharanija Madhavan et al.
CARCINOGENESIS (2016)
miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis
Yannan Fan et al.
NUCLEIC ACIDS RESEARCH (2016)
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer
David N. Danforth
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2016)
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
Silvia Antolin et al.
BMC CANCER (2015)
Nomogram to predict the likelihood of upgrade of atypical ductal hyperplasia diagnosed on a core needle biopsy in mammographically detected lesions
Thaer Khoury et al.
HISTOPATHOLOGY (2015)
Atypical Hyperplasia of the Breast - Risk Assessment and Management Options
Lynn C. Hartmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma
Cheng Wang et al.
SCIENTIFIC REPORTS (2015)
Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study
Lynn C. Hartmann et al.
CANCER PREVENTION RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions
Suzanne B. Coopey et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Analysis of serum genome-wide microRNAs for breast cancer detection
Qian Wu et al.
CLINICA CHIMICA ACTA (2012)
Reversal effects of traditional Chinese herbs on multidrug resistance in cancer cells
Lei Yang et al.
NATURAL PRODUCT RESEARCH (2011)
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
Timothy J. Key et al.
LANCET ONCOLOGY (2010)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The MicroRNA (miRNA): Overview of the RNA genes that modulate gene function
Shao-Yao Ying et al.
MOLECULAR BIOTECHNOLOGY (2008)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Share Paper
